Centralised quality assurance (QA) for PFTs in a multi-center inhaled insulin trial

R. L. Jensen, R. Crapo, B. Sun, D. B. Muchmore (Salt Lake City, Indianapolis, United States Of America)

Source: Annual Congress 2006 - Landmark developments in lung function testing: 2006
Session: Landmark developments in lung function testing: 2006
Session type: Oral Presentation
Number: 982

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. L. Jensen, R. Crapo, B. Sun, D. B. Muchmore (Salt Lake City, Indianapolis, United States Of America). Centralised quality assurance (QA) for PFTs in a multi-center inhaled insulin trial. Eur Respir J 2006; 28: Suppl. 50, 982

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effectiveness of a spirometric quality assurance program in a large-scale global COPD trial (UPLIFT)
Source: Eur Respir J 2004; 24: Suppl. 48, 32s
Year: 2004

Evaluation of biological quality control variance in a multi-center clinical trial for inhaled insulin
Source: Annual Congress 2007 - Quality, sleep and physiology
Year: 2007



First phase of a quality assurance audit of respiratory function laboratories within Scotland
Source: Annual Congress 2006 - Landmark developments in lung function testing: 2006
Year: 2006


Evaluation of data requirements to establish biologic quality control ranges in a multi-center clinical trial for inhaled insulin
Source: Annual Congress 2008 - New challenges and maintained quality: lung function for the future
Year: 2008


Evaluation of mechanical quality control methods used in a clinical trial for inhaled insulin
Source: Annual Congress 2007 - Quality, sleep and exercise - the ingredients for a perfect life!
Year: 2007


Pulmonary function of inhaled human insulin (Exubera®) in patients with type 2 diabetes: results from a 2-year study using standardized methodology
Source: Eur Respir J 2006; 28: Suppl. 50, 742s
Year: 2006

Pulmonary function of inhaled human insulin (Exubera®) in patients with type 1 diabetes: results from a 2-year study using standardized methodology
Source: Eur Respir J 2006; 28: Suppl. 50, 613s
Year: 2006

Impact of macitentan on the health-related quality of life (HRQoL) in pulmonary arterial hypertension (PAH): Results from a long-term randomised controlled trial
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013

A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire
Source: Eur Respir J 2005; 25: 31-40
Year: 2005



Effectiveness of a home-based pulmonary rehabilitation program compared to a hospital-based pulmonary rehabiltation program in COPD patients. A Spanish multicenter randomized trial
Source: Annual Congress 2006 - Organisation and programmes in pulmonary rehabilitation
Year: 2006


Implementing a pulmonary function laboratory (PFL) quality assurance (QA) program across a large health system
Source: International Congress 2019 – Quality, performance and interpretation of lung function testing
Year: 2019


Quality control of spirometry: a lesson from the BRONCUS trial
Source: Eur Respir J 2005; 26: 1104-1109
Year: 2005



A non-interventional observational trial to study the COPD treatment choices in routine clinical practice in Bulgaria
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016


Biological quality control for spirometry in a multi-centred clinical trial
Source: Annual Congress 2008 - Quality spirometry: the only spirometry!
Year: 2008


Efficacy and safety of abediterol (LAS100977) in patients with COPD: Phase II, randomised, crossover study
Source: Annual Congress 2013 –New bronchodilators for COPD management
Year: 2013

Quality control of DL,CO instruments in global clinical trials
Source: Eur Respir J 2009; 33: 828-834
Year: 2009



Effects of a 3-week pulmonary rehabilitation program in patients with idiopathic pulmonary fibrosis – A randomized, controlled trial
Source: International Congress 2016 – Novel approaches for pulmonary rehabilitation in chronic lung diseases
Year: 2016


Pulmonary rehabilitation in patients with group 3 pulmonary hypertension: evaluation of clinical outcomes, adherence and safety.
Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today
Year: 2019


Efficacy and safety of abediterol (LAS100977) in stable asthma: Phase II, randomized, crossover study
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013

Biologic quality control variability among pulmonary function testing systems in a large academic outpatient pulmonary function laboratory
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013